ZALEVSKY JONATHAN (Chief R&D Officer) sold 2.5% of their position (485.00 shares) of NEKTAR THERAPEUTICS on the open market
Open‑market sale worth $14.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/4/2025ACC: 0000950170-25-113130
Officer· Chief R&D Officer
Since Oct 2019
-485.00
Net shares
Net seller
$14.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
485.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−485.00
Price / share
$30.10
Trade value
$14.60K
% of position
2.5%
9/2/2025
19.67K→19.18K
Total
Net shares
−485.00
Net value
-$14.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/2/2025 | S · Sale | −485.00 | $30.10 | $14.60K | 2.5% | 19.67K | 19.18K |
| Total | −485.00 | -$14.60K | ||||||
Derivative Transactions0
No derivative transactions reported